Zentalis Pharmaceuticals, Inc. (ZNTL)
$2.64+5.18%Close
SELLCRISIS · day 22
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $188M
- Beta
- 1.86
- P/E (TTM)
- -1.09
- Short % float
- 12.27%
- Days to cover
- 4.1
- SI change
- +24.5%
- 1W
- +4.76%
- 1M
- -26.46%
- vs SPY 1W
- +3.60%
- vs SPY 1M
- -29.45%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on ZNTL?
- LOPJLB’s latest quantitative signal on Zentalis Pharmaceuticals, Inc. (ZNTL) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ZNTL in?
- Zentalis Pharmaceuticals, Inc. (ZNTL) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Zentalis Pharmaceuticals, Inc. (ZNTL) do?
- Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. T…